In addition to its alteration in expression level, RUNX3 protein mislocalization from nucleus to cytoplasm was commonly reckoned as another risk factor leading to worse prognosis in cancer of stomach [36], colorectum [37], and breast [38], while not in lung cancer [26]. Here, RUNX3 is linked to cancer.